Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience

Peptide receptor radionuclide therapy (PRRT) is a treatment option for well-differentiated, somatostatin receptor positive, unresectable or/and metastatic neuroendocrine tumors (NETs). Although high disease control rates seen with PRRT a significant number NET patients have a short progression-free...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Frontiers in endocrinology (Lausanne) Ročník 14; s. 1270421
Hlavní autori:	Vukomanovic, Vladimir, Nedic, Katarina Vuleta, Radojevic, Marija Zivkovic, Dagovic, Aleksandar, Milosavljevic, Neda, Markovic, Marina, Ignjatovic, Vladimir, Simic Vukomanovic, Ivana, Djukic, Svetlana, Sreckovic, Marijana, Backovic, Milena, Vuleta, Marko, Djukic, Aleksandar, Vukicevic, Verica, Ignjatovic, Vesna
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland Frontiers Media S.A 04.01.2024
Predmet:	Adult Aged Biomarkers Disease Progression Endocrinology functional tumors Humans Middle Aged NET Neuroendocrine Tumors - drug therapy Octreotide - therapeutic use overall survival progression free survival PRRT Radioisotopes - therapeutic use Receptors, Peptide - therapeutic use Retrospective Studies Serbia - epidemiology Serbia overall survival PRRT functional tumors NET progression free survival
ISSN:	1664-2392, 1664-2392
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!